Effects of progestin-only long-acting contraception on metabolic markers in obese women

Contraception

Volumn 88, Issue 3, 2013, Pages 418-425

  Bender, Nicole M ^a   Segall Gutierrez, Penina ^a   Najera, Sandy Oliver Lopez ^a   Stanczyk, Frank Z ^a   Montoro, Martin ^a   Mishell Jr , Daniel R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Beta cell function; Body mass index; Contraception; Contraceptive devices; Etonogestrel; Insulin resistance; Intrauterine; Obesity

Indexed keywords

ETONOGESTREL; GESTAGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEVONORGESTREL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAUTERINE CONTRACEPTIVE DEVICE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; SYSTOLIC BLOOD PRESSURE;

BETA-CELL FUNCTION; BODY MASS INDEX; CONTRACEPTION; CONTRACEPTIVE DEVICES; ETONOGESTREL; INSULIN RESISTANCE; INTRAUTERINE; OBESITY;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; FASTING; FEMALE; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; METABOLIC SYNDROME X; OBESITY; PROGESTINS; PROSPECTIVE STUDIES; WAIST CIRCUMFERENCE;

EID: 84883454764     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.12.007     Document Type: Article

References (21)

1. K. Flegal, M. Carroll, C. Ogden, and C. Johnson Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
2. S. Grundy, J. Cleeman, and S. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
3. I. Guelinckx, R. Devlieger, K. Beckers, and G. Vansant Maternal obesity: pregnancy complications, gestational weight gain and nutrition Obes Rev 9 2008 140 150
4. J. Trussel Contraceptive failure in the United States Contraception 83 2011 397 404
5. P. Segall-Gutierrez, A. Xiang, and R. Watanabe Changes in insulin sensitivity and β-cell responsiveness in obese women using depomedroxyprogesterone acetate Contraception 85 2012 36 41
6. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diabetes Care 27 2004 1487 1495
7. C.J. Glueck, N. Goldenberg, I. Sieve, and P. Wang An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet Metabolism 57 2008 954 960
8. American Diabetes Association Standards of medical care in diabetes- 2010 Diabetes Care 33 2010 S11 S61
9. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Early Release May 28, 2010:59.
10. International Physical Activity Questionaire. http://www.ipaq.ki.se/ipaq. htm accessed, online June 1, 2010.
11. Hispanic Health and Nutrition Examination Survey (HHANES) http://www.cdc.gov/nchs/nhanes/hhanes.htm accessed online June 1, 2010.
12. Implanon Full Prescribing Information. Merck % Co, Inc, Updated February 2012. http://www.spfiles.com/piimplanon.pd.pdf.
13. Mirena Full Prescribing Information. Bayer Pharmaceuticals. Updated October 2009. http://berlex.bayerhealthcare.com/html/products/pi/Mirena-PI.pdf.
14. J.C. Levy, D.R. Matthews, and M.P. Hermans Correct homeostasis model assessment (HOMA) evaluation uses the computer program Diabetes Care 21 1998 2191 2192
15. A. Biswas, O. Viegas, H. Bennink, T. Korver, and S. Ratnam Implanon contraceptive implants: effects on carbohydrate metabolism Contraception 63 2001 137 141
16. C. Meyer, M. Talbot, and H. Teede Effect of Implanon on insulin resistance in women with polycystic ovary syndrome Aust N Z J Obstet Gynaecol 45 2005 155 158
17. American Diabetes Association Standards of medical care in diabetes - 2012 Diabetes Care 35 2012 S11 S63
18. F. Kayikcioglu, M. Gunes, O. Ozdegirmenci, and A. Haberal Effects of levonorgestrel-releasing intrauterine system on glucose and lipid metabolism: a 1-year follow-up study Contraception 73 2006 528 531
19. N.Y. Woo, S. Liang, and K. Singh Effects of Mirena (levonorgestrel- releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism- a randomized comparative study Contraception 79 2009 24 28
20. L. Vicente, D. Mendonca, M. Dingle, R. Duarte, and J.M. Boavida Etonogestrel implant in women with diabetes mellitus Eur J Contracept Reprod Health Care 13 2008 387 395
21. C.L. Oderich, M.C.O. Wender, J.N. Lubianca, L.M. Santos, and G.C. de Mello Impact of etonogestrel-releasing implant and copper intrauterine device on carbohydrate metabolism: a comparative study Contraception 85 2012 173 176